PTGDS and Alzheimer disease: We investigated the PGD2 pathway in TgF344-AD (Tg-AD) transgenic rats at 11 mo of age because it is midway between the ages at which these rats present mild (at 6 mo of age) and robust (at 16 mo of age) AD pathology, as reported in the original study (Cohen et al, 2013).